SK AMERICAS, INC.

Organization · NY
Hires government relations

Semiconductors, Energy, Life Sciences

Who they hire

2024 · 4 filings · Environment/Superfund, Pharmacy, Science/Technology, Taxation/Internal Revenue Code, Trade (domestic/foreign)
$██,███ / qtrUnlock

What they lobby on

US trade and foreign direct investment climate and policies; US trade policy with respect to East Asia; Developments related to SKs investments and operations; US export control and supply chain policy; US semiconductor policies, including implementation of the CHIPS and Science Act funding; US policies related to green energy and electric vehicle batteries; implementation of the Inflation Reduction Act; US pharmaceutical policy and developments, including related to active pharmaceutical ingredients manufacturing
Taxation/Internal Revenue Code · 2024 Q2
Discuss investments related to green energy and electric vehicles; Monitor appropriations and finance issues
Environment/Superfund · 2024 Q2
General tax issues; Overview of company; Issues related to companys planned manufacturing and R&D investments in the U.S.; Inflation Reduction Act tax credit implementation; CHIPS investment tax credit implementation; R&D amortization; Tax policy proposals relating to semiconductor design activities
Taxation/Internal Revenue Code · 2024 Q2
Monitor proposals and issues related to biopharmaceuticals; Cancer Moonshot; Cell and Gene Therapy
Pharmacy · 2024 Q2
Overview of company; Issues relating to the strategic implications of trade restrictions and export controls as they relate to East Asia; Issues relating to, and strategic implications of, U.S. supply chain policy; Issues related to companys planned manufacturing and R&D investments in the U.S.; Issues relating to international trade; Issues relating to export control policy, including H.R. 7151, the Export Control Enforcement and Enhancement Act, and H.R. 8924, the Protecting American Innovation and Development Act; Monitor appropriations and finance issues
Trade (domestic/foreign) · 2024 Q2